logo
Select company
Select metric
Ticker Information

Ticker

AGEN

Company Name

AGENUS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AGENUS INC - Capital Expenditures to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AGEN - CapEx/OCF Historical data
DateCapital ExpenditureCapital Expenditures to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ -220K0%$ -127.78M
3/31/2025$ 522K0%$ -145.74M
12/31/2024$ 552K0%$ -158.31M
9/30/2024$ -2.31M0%$ -170.06M
6/30/2024$ 1.16M0%$ -182M
3/31/2024$ 4.78M0%$ -203.87M
12/31/2023$ 6.59M0%$ -224.2M
9/30/2023$ 11.73M0%$ -231.14M
6/30/2023$ 24M0%$ -198.1M
3/31/2023$ 28.36M0%$ -181.51M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AGENUS INC's latest trailing twelve months (TTM) CapEx/OCF stands at 0%.
  • Over the past 5 years, AGENUS INC's average CapEx/OCF has been 2370.62%.
  • The median CapEx/OCF for AGENUS INC during this period was 306.98%
  • AGENUS INC reached its highest CapEx/OCF over the past 5 years at 6527.31%.
  • The lowest CapEx/OCF recorded by AGENUS INC in the same timeframe 277.56%

AGENUS INC's CapEx/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx/OCF Benchmarks
CompanyCapEx/OCF
SGMO : SANGAMO THERAPEUTICS INC -ALEC : ALECTOR INC -BDTX : BLACK DIAMOND THERAPEUTICS INC -THTX : THERATECHNOLOGIES INC 0.16%PLX : PROTALIX BIOTHERAPEUTICS INC -STRO : SUTRO BIOPHARMA INC -SPRO : SPERO THERAPEUTICS INC -ENTA : ENANTA PHARMACEUTICALS INC -CSBR : CHAMPIONS ONCOLOGY INC 5.67%CHRS : COHERUS ONCOLOGY INC -

Definition of Capital Expenditures to Operating Cash Flow

[Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for AGENUS INC is calculated as follows: CapEx [ $ 3.69M ] / CF - Operations [ $ -135.29M ]
(=) CapEx/OCF [ 0% ]

AGEN - Capital Expenditures to Operating Cash Flow, Last 5 years

277.56%

Minimum

Dec 31, 2021

6527.31%

Maximum

Mar 31, 2022

2370.62%

Average

306.98%

Median

CapEx/OCF Benchmark Analysis

The chart above depicts the distribution of CapEx/OCF for companies in the Total Stock Market. The average CapEx/OCF of the companies is 31.82% with a standard deviation of 29.54%.
The following table provides additional summary stats:
CapEx/OCF in the Market:
filtered constituents2.35K
min0.01%
max128%
average31.82%
median22.41%
std29.54%